Bhavnagar
| Sl. No | Principal Investigator’s Name | Study Title | Phase | Protocol ID | Indication | Study Status | Link | Contact person & Phone Number |
|---|---|---|---|---|---|---|---|---|
| 1 | Dr. Manan Vaghela | A Prospective, Randomized, Multicenter, Comparative, Double-blind, Parallel study to Evaluate the Efficacy and Safety of Test Pertuzumab with Reference Pertuzumab in Patients with HER2 Positive Metastatic Breast Cancer. | Phase 3 | PERT.21.001 | MBC | Ongoing | https://clinicaltrials.gov/ct2/show/NCT05283837 | M.rafiq – 7434848441 |
| 2 | Dr. Nirav Thadeshwar | Phase IIb/III study to determine efficacy of Curcumin and Metformin to reduce the incidence of second primary tumors (SPT) of aero-digestive tract in patients with history of head and neck squamous cell carcinoma | Phase 2b/3 | Head & Neck Cancer | Ongoing | M.rafiq – 7434848441 | ||
| 3 | Dr. Manan Vaghela | “A Phase III, Prospective, Randomized, Multicenter, Comparative, Double blind, Parallel-group Study to Investigate the Efficacy, Safety, and Pharmacokinetics of ZRC-3276 Versus Opdivo® (Nivolumab) in Subjects with locally advanced or Metastatic Non-Small Cell Lung Cancer” | Phase 3 | NIVO.22.001 | NSCLC | FQ submitted | M.rafiq – 7434848441 |
